Cargando…
Graded Administration of Second Dose of Moderna and Pfizer-BioNTech COVID-19 mRNA Vaccines in Patients With Hypersensitivity to First Dose
Two mRNA coronavirus disease 2019 (COVID-19) vaccines, Moderna and Pfizer-BioNTech, require 2 doses for maximum efficacy. This case series reports the safety and immunogenicity of a graded administration of the second dose of the Moderna and Pfizer-BioNTech COVID-19 vaccines in patients with immedia...
Autores principales: | Tuong, Linh-An C, Capucilli, Peter, Staicu, Mary, Ramsey, Allison, Walsh, Edward E, Shahzad Mustafa, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8500168/ https://www.ncbi.nlm.nih.gov/pubmed/34873577 http://dx.doi.org/10.1093/ofid/ofab507 |
Ejemplares similares
-
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Safety and efficacy of graded dosing of Pfizer-BioNTech mRNA COVID-19 vaccine after an immediate hypersensitivity reaction to first dose
por: Regula, Prudhvi, et al.
Publicado: (2022) -
Detailed Dissection and Critical Evaluation of the Pfizer/BioNTech and Moderna mRNA Vaccines
por: Xia, Xuhua
Publicado: (2021) -
Myocarditis after third dose of Pfizer-BioNTech COVID-19 vaccine
Publicado: (2022) -
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022)